Building on the institution’s robust infrastructure, I am eager to continue advancing lipid-related research in cancer chemotherapy, with a focus on pioneering new avenues within this field. Specifically, my future projects will involve lipidomics to develop highly sensitive diagnostic tools for cancer detection and monitoring. Through the characterization of specific lipid markers, such as glycerophospholipids and sphingolipids, I intend to create diagnostic assays validated via mass spectrometry and liquid chromatography-mass spectrometry (LC-MS) that can be integrated into clinical oncology practices.
I am also committed to establishing a diverse and inclusive research group, prioritizing the selection of female and minority students. Studies have shown that underrepresented students benefit from group learning environments, so I will incorporate group-based study sessions within my lab and classroom settings to enhance learning outcomes. Additionally, I plan to provide workshops to support the professional growth of female and minority students, encouraging them to pursue academic careers in biomedical research. Beyond the university, I will actively engage with outreach programs to promote the importance of education among diverse communities, advocating for greater access to academic opportunities for all students.
This research statement reflects my ongoing commitment to impactful research in lipid metabolism and nanomedicine, as well as my dedication to fostering diversity and inclusion within the scientific community. Through my work, I strive to contribute meaningful advancements in cancer therapeutics while supporting a new generation of researchers who will drive the future of medical science forward.